Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00027417 · ClinicalTrials.gov registry record · Phase 3
Study of Triostat in Infants During Heart Surgery
A Phase 3 study, sponsored by Michael Portman.
- Completed
- Registry status
- Phase 3
- Development phase
- 195
- Enrollment target
NCT00027417 is a Phase 3 study that has completed, run by Michael Portman. The registered enrollment target is 195 participants.
The verdict
NCT00027417, a Phase 3 study, has completed, sponsored by Michael Portman.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 195 participants
- Enrollment target
Study Summary
This is a study to determine the safety and efficacy of liothyronine sodium/triiodothyronine (Triostat), a synthetic thyroid hormone, when given to infants with congenital heart disease during cardiopulmonary bypass surgery.
Interventions
- DRUG Liothyronine sodium/triiodothyronine
- PROCEDURE Cardiopulmonary bypass and cardiac surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 195 participants |
| Start Date | 2001-04 |
| Est. Completion | 2007-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00027417
The ClinicalTrials.gov registry entry for NCT00027417 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 195 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Michael Portman, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Liothyronine sodium/triiodothyronine is the first listed.
NCT00027417 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00027417 about?
NCT00027417 is a clinical study titled "Study of Triostat in Infants During Heart Surgery". This is a study to determine the safety and efficacy of liothyronine sodium/triiodothyronine (Triostat), a synthetic thyroid hormone, when given to infants with congenital heart disease during cardiopulmonary bypass surgery.
What is the current status of trial NCT00027417?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 195 participants. The study started on 2001-04. Estimated completion is 2007-08.
What interventions are being tested in trial NCT00027417?
The interventions under investigation include: Liothyronine sodium/triiodothyronine (DRUG), Cardiopulmonary bypass and cardiac surgery (PROCEDURE).
Who is sponsoring clinical trial NCT00027417?
This trial is sponsored by Michael Portman, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.